Date published: 2026-5-28

1-800-457-3801

SCBT Portrait Logo
Seach Input

D-type cyclin Activators

D-type cyclins, essential regulators of cell cycle progression, are critically influenced by specific chemical activators. These chemicals largely function by targeting associated cellular pathways, leading to either a direct or indirect enhancement of D-type cyclin levels. Predominantly, these chemicals target the Ras/Raf/MEK/ERK and PI3K/Akt pathways. Both pathways play significant roles in cell growth, differentiation, and survival, with intricate cross-talks and feedback mechanisms. D-type cyclin transcription, stability, and localization can be influenced when these pathways are activated. For instance, chemicals like EGF and PMA primarily focus on the Ras/Raf/MEK/ERK pathway, leading to augmented cyclin D1 transcription, a prominent D-type cyclin. On the other hand, molecules like Insulin and LPA act on the PI3K/Akt pathway. The activated Akt stimulates cyclin D translation and its nuclear localization, thereby increasing D-type cyclin levels.

It's worth noting the specificity and intricacy with which these activators function. While their primary roles might differ, their ultimate influence converges on modulating D-type cyclin levels, ensuring precise control over the cell cycle. The strategic intervention of these pathways showcases the delicate balance cells maintain to ensure homeostasis. By leveraging these chemical activators, one can harness the power of cellular pathways to influence the pivotal role of D-type cyclins in cell cycle progression. This understanding not only provides insights into the regulatory networks but also emphasizes the of chemical activators in modulating cellular outcomes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Insulin

11061-68-0sc-29062
sc-29062A
sc-29062B
100 mg
1 g
10 g
$156.00
$1248.00
$12508.00
82
(1)

Insulin activates the PI3K/Akt pathway. The activated Akt can stimulate cyclin D translation and promote its nuclear translocation, thereby raising D-type cyclin levels.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA can stimulate the Ras/Raf/MEK/ERK pathway. Activation of this pathway leads to an increase in cyclin D1 transcription, boosting D-type cyclin presence.

Lysophosphatidic Acid

325465-93-8sc-201053
sc-201053A
5 mg
25 mg
$98.00
$341.00
50
(3)

LPA activates the PI3K/Akt pathway, and the subsequent Akt activation can enhance cyclin D translation and its nuclear presence, elevating D-type cyclin levels.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin activates the Ras/Raf/MEK/ERK pathway. Enhanced ERK pathway activity increases cyclin D1 transcription, thus increasing D-type cyclin levels.

Phorbol-12,13-dibutyrate

37558-16-0sc-202285
1 mg
$124.00
3
(1)

PDBu can stimulate the Ras/Raf/MEK/ERK pathway. An active ERK pathway promotes cyclin D1 transcription, boosting D-type cyclin amounts.

β-Estradiol

50-28-2sc-204431
sc-204431A
500 mg
5 g
$63.00
$182.00
8
(1)

E2 can activate the PI3K/Akt pathway. Following Akt activation, cyclin D translation is enhanced, and its nuclear translocation is promoted, leading to increased D-type cyclin levels.

Cantharidin

56-25-7sc-201321
sc-201321A
25 mg
100 mg
$89.00
$279.00
6
(1)

Cantharidin inhibits PP2A, leading to activation of the ERK pathway. The activated ERK pathway then elevates cyclin D1 transcription, resulting in increased D-type cyclin levels.

Bryostatin 1

83314-01-6sc-201407
10 µg
$245.00
9
(1)

BRY activates the Ras/Raf/MEK/ERK pathway. The enhanced ERK pathway activity promotes cyclin D1 transcription, thus boosting D-type cyclin levels.

Oxotremorine M

63939-65-1sc-203656
100 mg
$148.00
3
(1)

Oxo-M can stimulate the Ras/Raf/MEK/ERK pathway. Activation of this pathway elevates cyclin D1 transcription, thus enhancing D-type cyclin presence.

Deoxycholic acid

83-44-3sc-214865
sc-214865A
sc-214865B
5 g
25 g
1 kg
$37.00
$67.00
$941.00
4
(2)

Deoxycholic acid activates the PI3K/Akt pathway. Activated Akt can stimulate cyclin D translation and promote its nuclear presence, thereby increasing D-type cyclin levels.